AcquisitionOther
INTEGRA LIFESCIENCES HOLDINGS CORP acquired Acclarent®
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
INTEGRA LIFESCIENCES HOLDINGS CORP -> Acclarent® · $275 million
The ear, nose and throat (ENT) category is a key area of strategic interest and highly complementary to the neurosurgery segment.
Open source record (SEC) ↗